Özet:

Purpose: This study aimed at comparing enteropathogens in children with acute gastroenteritis (AGE) with the Ruuska-Vesikari clinical score system and assessing rotavirus (RV) vaccination, the duration of stay in the hospital and the clinical severity. Methods: A retrospective data-based study, which included 642 children, who were hospitalized between 1 month and 18 years of age, applying to the pediatric department of a third stage hospital between 2014 and 2018, was carried out. Results: No patient has been to have been vaccinated with RV. Of six hundred and forty two patients, 179 were hospitalized due to RV enteritis (27.9%), 22 due to adenovirus enteritis (3.4%), 14 due to Entamoeba histolytica enteritis (2.2%), 11 due to Giardia enteritis (1.7%), and 413 due to unidentified AGE pathogens (64.3%). The Ruuska-Vesikari score was not identified related to the duration of stay at the hospital (p=0.31; r=0.04). In the winter season (26.8%) and in April (16.8%) RV enteritis was higher than in other times. Most RV cases (36.9%) are significantly frequently in the age range of 12 to 24 months. Clinical severity of children with AGE is classified as light, medium and severe clinical severity (14.5%, 35.5% and 50% respectively). In 73.2 percent of all RV cases, a clinic of severe disease (Ruuska-Vesikari score, ≥11) and a higher Ruuska-Vesikari score compared to other pathogens (p<0,001). Result: In this study, the most commonly identified AGE pathogen was RV in children without the RV vaccine. In future studies, studies that compare the facts of the RV vaccine and non-AGE will help develop health policies.

Anahtar Kelimeler: